What would you like to find?

Wellness since 1983

Infectious Test Panel

Influenza Panel with RSV and without RSV

Test is intended to detect H1N1 (pdm), Influenza A, Influenza B, Influenza A(H3) & Human Respiratory Syncytial Virus.

Influenza virus testing can inform clinical management when the results may influence clinical decisions such as whether to initiate antiviral treatment, perform other diagnostic testing, or to implement infection prevention and control measures for influenza. Influenza virus testing is recommended for all patients with suspected influenza who are being admitted to hospital.


Technique: Reverse Transcription-Polymerase Chain Reaction (RT-PCR) can identify the presence of influenza viral RNA or nucleic acids in respiratory specimens with very high sensitivity and specificity.

Sample requirement: nasopharyngeal or oropharyngeal swabs, broncheoalveolar lavage, tracheal aspirates, sputum.

Dengue/Chikungunya w/o Malaria

Test is designed for the qualitative detection of Dengue virus (DENV), Chikungunya virus (CHIKV) and Plasmodium spp. from various sources of clinical samples.


Technique: Real Time PCR technique.

Sample requirement: Whole blood in EDTA or serum or plasma.


This test identifies the SARS-CoV Virus that cause Covid 19. Sample testing is carried out only with ICMR, FDA approved kits.

COVID-19 Rapid Antigen Testing

Immunoassays that detect the presence of a specific viral antigen, which implies current viral infection performed on nasopharyngeal or nasal swab specimens placed directly into the assay’s extraction buffer or reagent.

Inflammatory Marker RT-PCR Test

Severe COVID-19 is associated with higher levels of inflammatory markers (IL-6, IL-10, TNF alpha) than a mild disease, so tracking these markers may allow early identification or even prediction of disease progression.


The Covid RT-PCR test report would be available around 4-24 hours. Urgent processing of samples is available at additional cost.

Launching Soon...

Extended Respiratory Panel

AyuGen will be launching an Extended Respiratory Panel that will accurately identify 33 different pathogens which includes Staphylococcus aureus, Streptococcus pneumonia, Klebsiella pneumonia, Mycoplasma pneumoniae, Salmonella spp., Streptococcus pyogens, Bordetella spp., Chlamydia pneumoniae, Streptococcus agalactiae, Acinetobacter baumanii, Pseudomonas aerugenosa, Legionella pneumonia, Haemophillus influenza A-F, Moraxella catarrhalis., Human Peracho Virus, Human corona Virus (alpha and beta), Parainfluenza 1-4, Influenza A Virus, Enterovirus, H3N2 Virus, Human Metapneumo Virus (A+B), Pandemic H1 influenza Virus, Influenzae B Virus, Influenzae C Virus, Adeno Virus, Human Respiratory Synctial Virus, Human Rhino Virus and Human Boca Virus from respiratory specimens (BAL/ Tracheal aspirate/ Sputum/ Nasopharyngeal aspirate in VTM vial) using Real time PCR technique.